URIXCOV Trademark

Trademark Overview

On Thursday, March 17, 2022, a trademark application was filed for URIXCOV with the United States Patent and Trademark Office. The USPTO has given the URIXCOV trademark a serial number of 97317611. The federal status of this trademark filing is REGISTERED as of Tuesday, February 27, 2024. This trademark is owned by GlaxoSmithKline Biologicals SA. The URIXCOV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
urixcov

General Information

Serial Number97317611
Word MarkURIXCOV
Filing DateThursday, March 17, 2022
Status700 - REGISTERED
Status DateTuesday, February 27, 2024
Registration Number7313095
Registration DateTuesday, February 27, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 12, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "URIXCOV" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxoSmithKline Biologicals SA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE
Party NameGlaxoSmithKline Biologicals SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRixensart B-1330
BE
Party NameGlaxoSmithKline Biologicals SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Trademark Events

Event DateEvent Description
Tuesday, February 27, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 27, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, December 12, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 12, 2023PUBLISHED FOR OPPOSITION
Wednesday, November 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 9, 20231(B) BASIS DELETED; NEW BASIS REQUESTED
Thursday, November 9, 2023NOTICE OF ALLOWANCE CANCELLED
Thursday, October 26, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, October 26, 2023PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Monday, October 23, 2023ASSIGNED TO PETITION STAFF
Wednesday, October 11, 2023TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, September 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 15, 2023SOU EXTENSION 1 GRANTED
Friday, September 15, 2023SOU EXTENSION 1 FILED
Friday, September 15, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, April 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 26, 2023LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, January 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 26, 2023ASSIGNED TO LIE
Saturday, December 31, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, December 31, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Saturday, December 31, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 28, 2022ASSIGNED TO EXAMINER
Wednesday, August 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 3, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, August 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 22, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 21, 2022NEW APPLICATION ENTERED

Related Keywords

urixcov treatment pharmaceutical preparations disorders diseases hepatological related vaccines oncological genitourinary